OPBX.F Stock Overview
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
OptiBiotix Health Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.22 |
| 52 Week High | UK£0.22 |
| 52 Week Low | UK£0.22 |
| Beta | 1.58 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPBX.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -4.7% | -3.7% |
| 1Y | n/a | -2.7% | 20.2% |
Return vs Industry: Insufficient data to determine how OPBX.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how OPBX.F performed against the US Market.
Price Volatility
| OPBX.F volatility | |
|---|---|
| OPBX.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OPBX.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OPBX.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 12 | Stephen O'Hara | www.optibiotix.com |
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages.
OptiBiotix Health Plc Fundamentals Summary
| OPBX.F fundamental statistics | |
|---|---|
| Market cap | US$15.11m |
| Earnings (TTM) | US$7.12m |
| Revenue (TTM) | US$1.51m |
2.1x
P/E Ratio10.0x
P/S RatioIs OPBX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPBX.F income statement (TTM) | |
|---|---|
| Revenue | UK£1.26m |
| Cost of Revenue | UK£544.47k |
| Gross Profit | UK£711.32k |
| Other Expenses | -UK£5.20m |
| Earnings | UK£5.91m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.065 |
| Gross Margin | 56.64% |
| Net Profit Margin | 470.44% |
| Debt/Equity Ratio | 0% |
How did OPBX.F perform over the long term?
See historical performance and comparison